-->

live project

2 MBA/ PGDM students are needed who have completed their first year for a live project of a industry. Stipend would be paid. Interested one can write back @ rk.singal58@gmail.com

Monday, April 7, 2014



Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats

TOKYO/MUMBAI Mon Apr 7, 2014 4:58pm IST
    
An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014. REUTERS-Danish Siddiqui
A man rides a motorcycle in front of the office of Ranbaxy Laboratories at Gurgaon, on the outskirts of New Delhi, June 13, 2013. REUTERS-Adnan Abidi-Files
1 of 2. An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014.
Credit: Reuters/Danish Siddiqui

Related Topics

Stocks

 
Sun Pharmaceutical Industries Ltd
SUN.NS
Rs588.10
+16.30+2.85%
04/07/2014
 
Ranbaxy Laboratories Ltd
RANB.NS
Rs445.75
-13.80-3.00%
04/07/2014
 
Daiichi Sankyo Co Ltd
4568.T
¥1,813
+58.00+3.30%
04/07/2014

 

 
 
 
 





TOKYO/MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd (SUN.NS) has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co (4568.T), and got Ranbaxy India-made drugs barred from the United States

0 comments:

Post a Comment

 
Share

Receive Quality Tutorials and Latest Job Information from Dr. Singhal Straight in Your Inbox by Submitting Your Email ID Below

Your Information Will Never Be Shared.